Episode 85 - Neha Krishnamohan - CFO & EVP Corporate Development at Artiva Biotherapeutics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d5/e4/1e/d5e41e47-bfe8-20ea-325b-c4cfd91dca77/mza_4324065226824686757.jpg/600x600bb.jpg

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

115 episodes

2 days ago

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.

Life Sciences

Science

RSS

All content for The BioHub: The Top Voices in Biotech is the property of Max Brennan - Biotech HeadHunter and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1704904841978-1a5f9097fe03.jpg

Episode 85 - Neha Krishnamohan - CFO & EVP Corporate Development at Artiva Biotherapeutics

The BioHub: The Top Voices in Biotech

26 minutes 57 seconds

1 week ago

Episode 85 - Neha Krishnamohan - CFO & EVP Corporate Development at Artiva Biotherapeutics

We were honoured to welcome Neha Krishnamohan, onto The BioHub.

Neha began her professional journey at Goldman Sachs in theHealthcare Investment Banking Group, focusing on mergers & acquisitions and strategic financings for biotech and med-tech companies. During her time there, she helped execute more than $100 billion in transactions across biopharma, diagnostics and tools.

Building on that foundation, Neha then moved into anoperational leadership role in biotech: she served as CFO and Executive Vice President of Corporate Development at Kinnate Biopharma, a precision-oncology company, where she led financial operations, business development and investor relations — working through strategic alternatives that culminated in asset transactions and acquisition.

Most recently, she joined Artiva Biotherapeutics, aclinical-stage company focused on off-the-shelf natural-killer (“NK”) cell therapies for autoimmune diseases and cancer, as CFO & EVP Corporate Development (April 2024). Her role is helping drive the company’s growthstrategy, financing, M&A and operational execution as Artiva scales its pipeline.